Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Saturday, September 12, 2015 1:06:38 PM
bullish
long term
http://www.biolifesolutions.com/biolife-investors/
## source: finance.yahoo.com
Mon, 31 Aug 2015 20:08:55 GMT ~ Is the BioLife Move Sustainable?
read full: http://finance.yahoo.com/news/biolife-move-sustainable-200855459.html
*********************************************************
Mon, 31 Aug 2015 15:53:06 GMT ~ BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint
[at noodls] - HypoThermosol® Cell Storage/Shipping Media to be Used in Commercial Manufacturing of Allogeneic Expanded Stem Cells for Complex Perianal Fistula in Crohn's Disease Patients BOTHELL, WA - August 31, 2015 ...
read full: http://www.noodls.com/view/6735D0834777AB9A40F8A414C710B7C8B10314F8
*********************************************************
Mon, 31 Aug 2015 15:10:00 GMT ~ BioLife Sciences (BLFS) Stock Spikes as Clinical Trial Meets Primary Endpoint
read full: http://www.thestreet.com/story/13271444/1/biolife-sciences-blfs-stock-spikes-as-clinical-trial-meets-primary-endpoint.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Mon, 31 Aug 2015 10:00:00 GMT ~ BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint
[PR Newswire] - BOTHELL, Wash., Aug. 31, 2015 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers ("BioLife" or the "Company"), today announced that its customer TiGenix NV, an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic expanded stem cells, recently disclosed that its lead compound Cx601 met the primary endpoint in the Phase III ADMIRE-CD trial of complex perianal fistula in Crohn's Disease patients. Cx601 is a suspension of allogeneic expanded adipose-derived stem cells (eASC) injected intra-lesionally.
read full: http://finance.yahoo.com/news/biolife-solutions-customer-tigenix-phase-100000868.html
*********************************************************
Thu, 27 Aug 2015 13:54:11 GMT ~ BioLife Solutions, Inc. Earnings Q2, 2015
read full: http://www.capitalcube.com/blog/index.php/biolife-solutions-inc-earnings-q2-2015/
*********************************************************
$BLFS charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$BLFS company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/BLFS/company-info
Ticker: $BLFS
OTC Market Place: Not Available
CIK code: 0000834365
Company name: BioLife Solutions, Inc.
Company website: http://www.biolifesolutions.com
Incorporated In: DE, USA
Business Description:
$BLFS share structure
## source: otcmarkets.com
Market Value: $28,928,562 a/o Sep 11, 2015
Shares Outstanding: 12,154,858 a/o Apr 30, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$BLFS extra dd links
Company name: BioLife Solutions, Inc.
Company website: http://www.biolifesolutions.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=BLFS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=BLFS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=BLFS+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/BLFS/news - http://finance.yahoo.com/q/h?s=BLFS+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/BLFS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/BLFS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=BLFS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/BLFS
DTCC (dtcc.com): http://search2.dtcc.com/?q=BioLife+Solutions%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=BioLife+Solutions%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=BioLife+Solutions%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.biolifesolutions.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.biolifesolutions.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.biolifesolutions.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/BLFS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000834365&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/BLFS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/BLFS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=BLFS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=BLFS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/BLFS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=BLFS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=BLFS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=BLFS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=BLFS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=BLFS+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/BLFS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=BLFS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/BLFS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=BLFS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/BLFS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/BLFS/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/BLFS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/BLFS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/BLFS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=BLFS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=BLFS
$BLFS DD Notes ~ http://www.ddnotesmaker.com/BLFS
Recent BLFS News
- BioLife Solutions Announces the Divestiture of its Stirling Freezer Business • PR Newswire (US) • 04/18/2024 12:05:00 PM
- BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences • PR Newswire (US) • 03/04/2024 01:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:05:54 PM
- BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 02/29/2024 09:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:52:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:51:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:51:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:51:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:51:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:50:58 PM
- BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024 • PR Newswire (US) • 02/20/2024 01:03:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/02/2024 03:11:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 10:10:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:16:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:30:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:30:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:30:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:29:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:29:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:29:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:29:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:42:02 PM
- BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue • PR Newswire (US) • 01/08/2024 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:04:58 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM